(Q48268762)

10 February 2018

title

Population pharmacokinetic and pharmacodynamic analysis in allergic diseases. (English)

1 reference

10 February 2018

1 reference

1 reference

Mark Lovern

1

1 reference

10 February 2018

Maria-Laura Sargentini-Maier

series ordinal

2

1 reference

10 February 2018

Christian Otoul

series ordinal

3

1 reference

10 February 2018

Jean-Baptiste Watelet

series ordinal

4

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 2009

1 reference

10 February 2018

published in

Drug Metabolism Reviews

1 reference

10 February 2018

volume

41

1 reference

10 February 2018

issue

3

1 reference

10 February 2018

page(s)

475-485

1 reference

10 February 2018

Role of modelling and simulation in Phase I drug development

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Applications of population pharmacokinetics in current drug labelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Analysis of population pharmacokinetic data using NONMEM and WinBUGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Plasma concentration clamping in the rat using a computer-controlled infusion pump.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

A new solution-based intranasal triamcinolone acetonide formulation in patients with perennial allergic rhinitis: how does the pharmacokinetic/pharmacodynamic profile for cortisol suppression compare with an aqueous suspension-based formulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

A population pharmacokinetic model for montelukast disposition in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Population Pharmacokinetics/Dynamics*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Continuous patient monitoring with a small digital computer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10837450902891543

10.1080/10837450902891543

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018